Management and outcome of myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia relapsing after allogeneic stem cell transplantation: a retrospective analysis on 888 patients by the MDS Subcommittee of the EBMT Chronic Leukaemia Working Party

MLA

Schmid, Christoph, et al. Management and Outcome of Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukaemia Relapsing after Allogeneic Stem Cell Transplantation: A Retrospective Analysis on 888 Patients by the MDS Subcommittee of the EBMT Chronic Leukaemia Working Party. Nov. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3341..343898f1157bf31032129ab4b8832308&authtype=sso&custid=ns315887.

APA

Schmid, C., van Biezen, A., Brand, R., Finke, J., Volin, L., Vitek, A., Selleslag, D., Heim, D., van dem Borne, P., Ganser, A., Mohty, M., Boogaerts, M., de Witte, T., & Kroeger, N. (2022). Management and outcome of myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia relapsing after allogeneic stem cell transplantation: a retrospective analysis on 888 patients by the MDS Subcommittee of the EBMT Chronic Leukaemia Working Party.

Chicago

Schmid, Christoph, Anja van Biezen, R. Brand, J. Finke, L. Volin, Antonin Vitek, Dominik Selleslag, et al. 2022. “Management and Outcome of Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukaemia Relapsing after Allogeneic Stem Cell Transplantation: A Retrospective Analysis on 888 Patients by the MDS Subcommittee of the EBMT Chronic Leukaemia Working Party,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3341..343898f1157bf31032129ab4b8832308&authtype=sso&custid=ns315887.